What makes Turmeric the King of the Rhizomes? What is the secret of turmeric? The answer is something called curcumin
Curcumin has attracted considerable attention for its potential therapeutic effects in various diseases, such as inflammation, cancer, diabetes, and neurodegeneration. However, the molecular mechanisms of action of curcumin are not fully understood. The following excerpt is a summary of some of the recent advances in elucidating the biological targets and pathways modulated by curcumin.
Curcumin is a pleiotropic (Pleiotropy is the expression of multiple traits by a single gene) molecule that can interact with multiple targets, such as:
- enzymes
- receptors
- transcription factors
- signaling molecules
Some of the well-known targets of curcumin include:
- cyclooxygenase-2 (COX-2),
- nuclear factor-kappa B (NF-κB),
- tumor necrosis factor-alpha (TNF-α),
- reactive oxygen species (ROS), and
- protein kinases.
By inhibiting these targets, curcumin can modulate various cellular processes, such as inflammation, oxidative stress, apoptosis, cell cycle, angiogenesis, and metastasis. For example, curcumin can suppress the activation of NF-κB, a key transcription factor that regulates the expression of pro-inflammatory genes, such as COX-2, TNF-α, and interleukin-6 (IL-6).
Curcumin can also scavenge ROS and enhance the activity of antioxidant enzymes, such as glutathione peroxidase and catalase, thus reducing oxidative damage and inflammation. Furthermore, curcumin can induce apoptosis and cell cycle arrest in cancer cells by modulating the expression and activity of various proteins, such as Bcl-2, Bax, caspases, p53, and cyclins.
Curcumin can also inhibit angiogenesis and metastasis by affecting the expression and function of vascular endothelial growth factor (VEGF), matrix metalloproteinases (MMPs), and integrins.
Curcumin is a promising natural agent that can modulate multiple targets and pathways involved in various diseases. However, the clinical application of curcumin is limited by its poor bioavailability, stability, and solubility. Therefore, further studies are needed to optimize the delivery and formulation of curcumin, as well as to elucidate its pharmacokinetics, pharmacodynamics, and safety profile. Moreover, more clinical trials are required to validate the efficacy and dose-response of curcumin in different disease settings.
But regardless of the vast amount of what is unknown about curcumin, the real life effects have been documented and verified for many decades in various parts of the world…and you certainly don’t have to understand the biochemistry of curcumin in order to enjoy the benefits of turmeric, King of the Rhizomes.